跳到正文
原文
Medical Xpress·· 9 天前AI 评分60

数字支持的治疗模型改善痛风血尿酸目标达标

Digitally supported care model improves serum urate target attainment in gout

AI 导读

一项针对280名痛风患者的随机对照试验显示,数字支持的治疗模型在12个月内显著提高了血尿酸目标达标率,并降低了痛风发作频率,同时改善了代谢指标。

正文
gout
Credit: Pixabay/CC0 Public Domain

For patients with gout, a physician-supervised treat-to-target (T2T) care model improves serum urate (SUA) target attainment, according to a study published online Nov. 4 in Arthritis & Rheumatology.

Yining Gao, M.D., from the Tongji University School of Medicine in Shanghai, and colleagues conducted a 12-month, single-center, open-label superiority randomized controlled trial involving 280 men with gout. Participants were randomly assigned to an integrated physician-supervised T2T digitally supported care model (the "1CARE" platform combining automated behavioral reminders, tiered education, remote SUA monitoring and weekly physician review [App-Led Care]) or usual care (140 to each group).

The researchers found that at 12 months, 85.0% and 48.6% of participants in the App-Led Care group and the usual care group, respectively, achieved the primary therapeutic target of SUA <360 μmol/L (risk ratio, 1.75). In addition, significantly lower annualized gout flare frequency was seen in the App-Led Care group (0.02 versus 0.10 flares/year).

The App-Led Care group had favorable exploratory metabolic outcomes, with greater reductions in fasting plasma glucose, hemoglobin A1c, total cholesterol and low-density lipoprotein cholesterol, together with higher adherence to medication. The two groups had comparable adverse event rates.

"The integrated, physician-supervised, digitally supported '1CARE' care model demonstrated superiority over usual care in achieving serum urate targets and reducing gout flare frequency over 12 months, with exploratory evidence of favorable metabolic cobenefits," the authors write.

More information

Yining Gao et al., Effects of a Smartphone‐Enabled, Physician‐Supervised Treat‐to‐Target Model for Gout Management: A 12‐Month Randomized Controlled Trial, Arthritis & Rheumatology (2026). DOI: 10.1002/art.70387

Key medical concepts

Gout

Clinical categories

Rheumatology

Who's behind this story?

Robert Egan

Robert Egan

Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →

Copyright © 2026 HealthDay. All rights reserved.

Citation: Digitally supported care model improves serum urate target attainment in gout (2026, November 10) retrieved 10 November 2026 from https://medicalxpress.com/news/2026-11-digitally-serum-urate-gout.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com